Send to a Friend Font Size: Increase Decrease

William Ackman

William Ackman's Portfolio

Ticker	# of Shares	Price	Value
	15,095,528	$195.32	$2,948,458,529
GOOG	9,377,195	$298.30	$2,797,217,269
HLT	9,332,853	$298.64	$2,787,163,220
LOW	7,468,850	$251.89	$1,881,328,627
QSR	23,348,135	$73.98	$1,727,295,028
HHC	16,570,228	$78.76	$1,305,071,158
GOOGL	2,185,000	$298.52	$652,266,200
CMG	953,608	$35.37	$33,729,115
View Additional Portfolio Information »

Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.

Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).

Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.

In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Nov 9, 2015 11:36AM Bill Ackman said Valeant Pharma (VRX) is its largest position
Nov 9, 2015 11:31AM Ackman Discuses Valeant Pharma (VRX) on Today's Call
Nov 9, 2015 08:20AM Ackman says Valeant likely to pay down debt in the next 18 months
Nov 6, 2015 10:08PM Valeant investors divided on fate of CEO Pearson
Nov 6, 2015 03:36PM Big bets on Valeant hit some hedge funds hard in October
Nov 6, 2015 08:37AM Goldman sold 1.3 million Valeant shares backing loan to CEO, Valeant says
Nov 5, 2015 03:42PM Is a 'Fire Sale' in Store for Valeant Pharma (VRX)?
Nov 5, 2015 02:43PM Ackman, in email, says supports Valeant CEO Pearson
Nov 5, 2015 02:23PM Bill Ackman supports Valeant Pharma (VRX) CEO Pearson - CNBC
Nov 5, 2015 12:02PM Three Reasons Valeant (VRX) is Plunging Today
Nov 5, 2015 10:58AM Ackman backs Valeant CEO as shares tumble to 2-1/2 year lows
Nov 5, 2015 10:42AM Valeant (VRX) In Free Fall as Large Holders May Finally Be Crying Uncle
Nov 5, 2015 10:25AM Ackman Stocks Trade Lower on Valeant (VRX) Free-Fall
Nov 4, 2015 11:55AM Icahn Speculation Around Valeant (VRX) Grows Following Interview
Nov 3, 2015 09:46AM Valeant's crisis fuels feud between Ackman and Australian fund manager Hempton
Nov 2, 2015 09:27PM Bill Ackman's Pershing Square Down 19% YTD (VRX)
Nov 2, 2015 01:19PM Goldman Sachs says Valeant has long road ahead, cuts rating
Nov 2, 2015 12:18PM Citron's Left said "I have nothing with Bill Ackman. This is about Valeant (VRX)"
Nov 2, 2015 10:26AM Citron publishes no new allegations against Valeant, shares rise
Nov 1, 2015 07:32PM Citron Research: Don't Expect Anything Earth-Shattering on Valeant (VRX) Come Monday
Oct 30, 2015 04:10PM Top 10 News for 10/26 - 10/30: Valeant's Saga Continues Marching Along; Walgreens Boots Moves to Acquire Rival
Oct 30, 2015 03:23PM Valeant Pharma (VRX) Trades Near Lows Heading Into Weekend
Oct 30, 2015 01:01PM Bill Ackman's conference call on Valeant Pharma (VRX) ends
Oct 30, 2015 12:57PM Valeant Pharmaceuticals (VRX) Bull-Bear Debate Rages
Oct 30, 2015 11:11AM Bill Ackman said their average cost on Valeant Pharma (VRX) is $186
Oct 30, 2015 10:23AM Bill Ackman Said Fund 'Fully Invested'; 'Scraped Together Funds' to Buy Recent 2M Shares
Oct 30, 2015 10:20AM Bill Ackman Compares Valeant Pharma (VRX) to American Express (AXP) in 1960s; Notes Buffett Bought on Panic
Oct 30, 2015 10:14AM Bill Ackman said Valeant Pharma (VRX) worth $180-$240 Near-Term, $262-$350 Long-Term
Oct 30, 2015 10:12AM Valeant (VRX) Trading at Less than 8X 2016 EPS Ex-Philidor - Ackman
Oct 30, 2015 10:08AM Bill Ackman calls Valeant (VRX) Bausch & Lombâ�� 'best in the business'
Oct 30, 2015 10:04AM Bill Ackman said the $100 million option on Philidor was for 'exclusivity' (VRX)
Oct 30, 2015 10:04AM Ackman: Valeant's main problem is PR, not fraud
Oct 30, 2015 09:26AM Amazon (AMZN) Should Distribute Drugs - Ackman
Oct 30, 2015 09:14AM Pershing Square Valeant Pharma (VRX) Conf. Call Up and Running after Technical Difficulties
Oct 30, 2015 08:53AM Valeant Pharma (VRX) on Watch as Ahead of Pershing Square Conference Call
Oct 30, 2015 08:49AM I Hope Bill Ackman Has Done More Research on Valeant (VRX) Than Herbalife: Herbalife (HLF)
Oct 30, 2015 05:42AM Valeant says Philidor pharmacy shutting down as it cuts ties
Oct 28, 2015 04:53PM Ackman's Pershing Square Down 15.9% YTD
Oct 27, 2015 05:09PM ValueAct rallies Valeant investors as company fends off attack: source
Oct 27, 2015 10:04AM Ackman to hold call to discuss investment in Valeant
Oct 27, 2015 06:41AM Ackman's Pershing Square to Hold Conf. Call About Valeant Pharma (VRX) Investment
Oct 26, 2015 06:37PM Short interest piled on Valeant ahead of scathing report
Oct 23, 2015 09:08AM Valeant slump poses big threat to small hedge funds
Oct 22, 2015 10:51AM Valeant vows to refute 'phantom sales' allegations
Oct 21, 2015 03:34PM Pershing Square's Ackman Down ~40% on Valeant Pharma (VRX) Bet
Oct 21, 2015 02:58PM Ackman Affirms Buying Another 2M Valeant Pharma (VRX) Shares; Hasn't Sold Any - Bloomberg
Oct 21, 2015 02:42PM UPDATE: Ackman Bought 2M More Shares of Valeant Pharma (VRX) - CNBC
Oct 21, 2015 11:13AM Hedge Funds on Edge as Valeant Pharma (VRX) Sinks
Oct 21, 2015 07:08AM Wall St. declines; Valeant, healthcare weigh
Sep 28, 2015 02:03PM Democrats take aim at drug prices, prompting sharp drops in biotech stocks

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed